Repligen | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Agilent USD 1.47B 138M 2025-01
Align Technology USD 873.01M 170.88M 2025-03
Bio Techne USD 140.67M 36.88M 2025-03
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Bruker USD 184.2M 800K 2025-03
Charles River Laboratories USD 229.36M 34.75M 2025-03
Danaher USD 1.99B 85M 2025-03
Dentsply International USD 272M 24M 2024-12
Exact Sciences USD 6.11M 773K 2025-03
General Electric USD 12.4B 1.21B 2025-03
Henry Schein USD 122M 4M 2024-12
Illumina USD 1.13B 258M 2024-12
IQVIA Holdings USD 1.74B 38M 2025-03
Mettler Toledo International USD 64.29M 4.93M 2025-03
Myriad Genetics USD 91.8M 10.6M 2025-03
Pfizer USD 1.43B 387M 2025-03
Repligen USD 697.23M 60.13M 2025-03
Revvity USD 1.14B 25.78M 2025-03
Standard Biotools USD 166.73M 43.92M 2024-12
Thermo Fisher Scientific USD 4.13B 125M 2025-03
Waters USD 382.87M 58.45M 2025-03
West Pharmaceutical Services USD 404.2M 80.4M 2025-03



Repligen Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.